ANTI CCP (ACCP)

The anti-cyclic citrullinated peptide (anti-CCP) test detects autoantibodies targeting citrullinated peptides, which are often present in individuals with rheumatoid arthritis (RA). The anti-CCP test is highly specific for RA and is used to help diagnose the condition, especially in its early stages. Elevated levels of anti-CCP antibodies can indicate a higher risk of developing RA and are associated with more severe disease and joint damage. This test is valuable for distinguishing RA from other types of arthritis and guiding treatment plans to manage symptoms, reduce inflammation, and prevent joint destruction.